Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Hepatitis

  Free Subscription


Articles published in PLoS Pathog

Retrieve available abstracts of 46 articles:
HTML format



Single Articles


    February 2024
  1. BENDER D, Koulouri A, Wen X, Glitscher M, et al
    Guanylate-binding protein 1 acts as a pro-viral factor for the life cycle of hepatitis C virus.
    PLoS Pathog. 2024;20:e1011976.
    PubMed     Abstract available


  2. ZHENG Y, Wang M, Yin J, Duan Y, et al
    Hepatitis B virus RNAs co-opt ELAVL1 for stabilization and CRM1-dependent nuclear export.
    PLoS Pathog. 2024;20:e1011999.
    PubMed     Abstract available


    January 2024
  3. TSUKUDA S, Harris JM, Magri A, Balfe P, et al
    The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome.
    PLoS Pathog. 2024;20:e1011917.
    PubMed     Abstract available


    December 2023
  4. FENG J, Xu T, He M, Li J, et al
    NSUN2-mediated m5C modification of HBV RNA positively regulates HBV replication.
    PLoS Pathog. 2023;19:e1011808.
    PubMed     Abstract available


  5. SO CW, Sourisseau M, Sarwar S, Evans MJ, et al
    Roles of epidermal growth factor receptor, claudin-1 and occludin in multi-step entry of hepatitis C virus into polarized hepatoma spheroids.
    PLoS Pathog. 2023;19:e1011887.
    PubMed     Abstract available


    November 2023
  6. CARRIQUI-MADRONAL B, Sheldon J, Duven M, Stegmann C, et al
    The matrix metalloproteinase ADAM10 supports hepatitis C virus entry and cell-to-cell spread via its sheddase activity.
    PLoS Pathog. 2023;19:e1011759.
    PubMed     Abstract available


    October 2023
  7. DRAVID P, Murthy S, Attia Z, Cassady C, et al
    Phenotype and fate of liver-resident CD8 T cells during acute and chronic hepacivirus infection.
    PLoS Pathog. 2023;19:e1011697.
    PubMed     Abstract available


    September 2023
  8. SUBRAMANIAM S, Fares-Gusmao R, Sato S, Cullen JM, et al
    Distinct disease features of acute and persistent genotype 3 hepatitis E virus infection in immunocompetent and immunosuppressed Mongolian gerbils.
    PLoS Pathog. 2023;19:e1011664.
    PubMed     Abstract available


    August 2023
  9. OHTA K, Ito M, Chida T, Nakashima K, et al
    Role of hepcidin upregulation and proteolytic cleavage of ferroportin 1 in hepatitis C virus-induced iron accumulation.
    PLoS Pathog. 2023;19:e1011591.
    PubMed     Abstract available


  10. RAHEJA H, George B, Tripathi SK, Saha S, et al
    Hepatitis C virus non-structural proteins modulate cellular kinases for increased cytoplasmic abundance of host factor HuR and facilitate viral replication.
    PLoS Pathog. 2023;19:e1011552.
    PubMed     Abstract available


  11. EWART G, Bobardt M, Bentzen BH, Yan Y, et al
    Post-infection treatment with the E protein inhibitor BIT225 reduces disease severity and increases survival of K18-hACE2 transgenic mice infected with a lethal dose of SARS-CoV-2.
    PLoS Pathog. 2023;19:e1011328.
    PubMed     Abstract available


    July 2023
  12. PHAM MT, Lee JY, Ritter C, Thielemann R, et al
    Endosomal egress and intercellular transmission of hepatic ApoE-containing lipoproteins and its exploitation by the hepatitis C virus.
    PLoS Pathog. 2023;19:e1011052.
    PubMed     Abstract available


  13. PIERCE DM, Buchanan FJT, Macrae FL, Mills JT, et al
    Thrombin cleavage of the hepatitis E virus polyprotein at multiple conserved locations is required for genome replication.
    PLoS Pathog. 2023;19:e1011529.
    PubMed     Abstract available


    June 2023
  14. JU X, Yu Y, Ren W, Dong L, et al
    The PRMT5/WDR77 complex restricts hepatitis E virus replication.
    PLoS Pathog. 2023;19:e1011434.
    PubMed     Abstract available


    May 2023
  15. ZHENG Y, Wang M, Li S, Bu Y, et al
    Hepatitis B virus hijacks TSG101 to facilitate egress via multiple vesicle bodies.
    PLoS Pathog. 2023;19:e1011382.
    PubMed     Abstract available


    February 2023
  16. CHEN S, Harris M
    NS5A domain I antagonises PKR to facilitate the assembly of infectious hepatitis C virus particles.
    PLoS Pathog. 2023;19:e1010812.
    PubMed     Abstract available


    November 2022
  17. MAZOUZ S, Salinas E, Bedard N, Filali A, et al
    Differential immune transcriptomic profiles between vaccinated and resolved HCV reinfected subjects.
    PLoS Pathog. 2022;18:e1010968.
    PubMed     Abstract available


    October 2022
  18. ISKEN O, Pham MT, Schwanke H, Schlotthauer F, et al
    Characterization of a multipurpose NS3 surface patch coordinating HCV replicase assembly and virion morphogenesis.
    PLoS Pathog. 2022;18:e1010895.
    PubMed     Abstract available


    August 2022
  19. HERVOUET K, Ferrie M, Ankavay M, Montpellier C, et al
    An Arginine-Rich Motif in the ORF2 capsid protein regulates the hepatitis E virus lifecycle and interactions with the host cell.
    PLoS Pathog. 2022;18:e1010798.
    PubMed     Abstract available


  20. SHIRASAKI T, Feng H, Duyvesteyn HME, Fusco WG, et al
    Nonlytic cellular release of hepatitis A virus requires dual capsid recruitment of the ESCRT-associated Bro1 domain proteins HD-PTP and ALIX.
    PLoS Pathog. 2022;18:e1010543.
    PubMed     Abstract available


    July 2022
  21. CARTWRIGHT HN, Barbeau DJ, Doyle JD, Klein E, et al
    Genetic diversity of collaborative cross mice enables identification of novel rift valley fever virus encephalitis model.
    PLoS Pathog. 2022;18:e1010649.
    PubMed     Abstract available


  22. HONG X, Menne S, Hu J
    Constrained evolution of overlapping genes in viral host adaptation: Acquisition of glycosylation motifs in hepadnaviral precore/core genes.
    PLoS Pathog. 2022;18:e1010739.
    PubMed     Abstract available


    June 2022
  23. HEUSS C, Rothhaar P, Burm R, Lee JY, et al
    A Hepatitis C virus genotype 1b post-transplant isolate with high replication efficiency in cell culture and its adaptation to infectious virus production in vitro and in vivo.
    PLoS Pathog. 2022;18:e1010472.
    PubMed     Abstract available


  24. ISKEN O, Walther T, Wong-Dilworth L, Rehders D, et al
    Identification of NS2 determinants stimulating intrinsic HCV NS2 protease activity.
    PLoS Pathog. 2022;18:e1010644.
    PubMed     Abstract available


  25. HONG X, Kawasawa YI, Menne S, Hu J, et al
    Host cell-dependent late entry step as determinant of Hepatitis B virus infection.
    PLoS Pathog. 2022;18:e1010633.
    PubMed     Abstract available


  26. KIM ES, Zhou J, Zhang H, Marchetti A, et al
    Hepatitis B virus X protein counteracts high mobility group box 1 protein-mediated epigenetic silencing of covalently closed circular DNA.
    PLoS Pathog. 2022;18:e1010576.
    PubMed     Abstract available


    May 2022
  27. HUM NR, Bourguet FA, Sebastian A, Lam D, et al
    MAVS mediates a protective immune response in the brain to Rift Valley fever virus.
    PLoS Pathog. 2022;18:e1010231.
    PubMed     Abstract available


    March 2022
  28. DORNBRACK K, Beck J, Nassal M
    Relaxing the restricted structural dynamics in the human hepatitis B virus RNA encapsidation signal enables replication initiation in vitro.
    PLoS Pathog. 2022;18:e1010362.
    PubMed     Abstract available


    February 2022
  29. ALZAHRANI N, Wu MJ, Sousa CF, Kalinina OV, et al
    SPCS1-Dependent E2-p7 processing determines HCV Assembly efficiency.
    PLoS Pathog. 2022;18:e1010310.
    PubMed     Abstract available


    January 2022
  30. LIN J, Yin L, Xu XZ, Sun HC, et al
    Bay41-4109-induced aberrant polymers of hepatitis b capsid proteins are removed via STUB1-promoted p62-mediated macroautophagy.
    PLoS Pathog. 2022;18:e1010204.
    PubMed     Abstract available


  31. OGEGA CO, Skinner NE, Flyak AI, Clark KE, et al
    B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection.
    PLoS Pathog. 2022;18:e1010179.
    PubMed     Abstract available


  32. SABARIEGOS R, Ortega-Prieto AM, Diaz-Martinez L, Grande-Perez A, et al
    Guanosine inhibits hepatitis C virus replication and increases indel frequencies, associated with altered intracellular nucleotide pools.
    PLoS Pathog. 2022;18:e1010210.
    PubMed     Abstract available


    December 2021
  33. SAADI F, Chakravarty D, Kumar S, Kamble M, et al
    CD40L protects against mouse hepatitis virus-induced neuroinflammatory demyelination.
    PLoS Pathog. 2021;17:e1010059.
    PubMed     Abstract available


    November 2021
  34. LIU H, Cheng J, Viswanathan U, Chang J, et al
    Amino acid residues at core protein dimer-dimer interface modulate multiple steps of hepatitis B virus replication and HBeAg biogenesis.
    PLoS Pathog. 2021;17:e1010057.
    PubMed     Abstract available


    September 2021
  35. SUN L, Li Y, Misumi I, Gonzalez-Lopez O, et al
    IRF3-mediated pathogenicity in a murine model of human hepatitis A.
    PLoS Pathog. 2021;17:e1009960.
    PubMed     Abstract available


  36. DANESH G, Virlogeux V, Ramiere C, Charre C, et al
    Quantifying transmission dynamics of acute hepatitis C virus infections in a heterogeneous population using sequence data.
    PLoS Pathog. 2021;17:e1009916.
    PubMed     Abstract available


  37. WANG B, Zhu Y, Yu C, Zhang C, et al
    Hepatitis C virus induces oxidation and degradation of apolipoprotein B to enhance lipid accumulation and promote viral production.
    PLoS Pathog. 2021;17:e1009889.
    PubMed     Abstract available


    August 2021
  38. BURCHILL MA, Salomon MP, Golden-Mason L, Wieland A, et al
    Single-cell transcriptomic analyses of T cells in chronic HCV-infected patients dominated by DAA-induced interferon signaling changes.
    PLoS Pathog. 2021;17:e1009799.
    PubMed     Abstract available


  39. YUE L, Li C, Xu M, Wu M, et al
    Probing the spatiotemporal patterns of HBV multiplication reveals novel features of its subcellular processes.
    PLoS Pathog. 2021;17:e1009838.
    PubMed     Abstract available


    July 2021
  40. LI Y, Luo G
    Human low-density lipoprotein receptor plays an important role in hepatitis B virus infection.
    PLoS Pathog. 2021;17:e1009722.
    PubMed     Abstract available


  41. OLESEN CH, Augestad EH, Troise F, Bukh J, et al
    In vitro adaptation and characterization of attenuated hypervariable region 1 swap chimeras of hepatitis C virus.
    PLoS Pathog. 2021;17:e1009720.
    PubMed     Abstract available


  42. YU T, Yang Q, Tian F, Chang H, et al
    Glycometabolism regulates hepatitis C virus release.
    PLoS Pathog. 2021;17:e1009746.
    PubMed     Abstract available


    May 2021
  43. BAUDI I, Isogawa M, Moalli F, Onishi M, et al
    Interferon signaling suppresses the unfolded protein response and induces cell death in hepatocytes accumulating hepatitis B surface antigen.
    PLoS Pathog. 2021;17:e1009228.
    PubMed     Abstract available


    April 2021
  44. SCHOBEL A, Nguyen-Dinh V, Schumann GG, Herker E, et al
    Hepatitis C virus infection restricts human LINE-1 retrotransposition in hepatoma cells.
    PLoS Pathog. 2021;17:e1009496.
    PubMed     Abstract available


    March 2021
  45. HARTLAGE AS, Dravid P, Walker CM, Kapoor A, et al
    Adenovirus-vectored T cell vaccine for hepacivirus shows reduced effectiveness against a CD8 T cell escape variant in rats.
    PLoS Pathog. 2021;17:e1009391.
    PubMed     Abstract available


    January 2021
  46. WELLS AI, Grimes KA, Kim K, Branche E, et al
    Human FcRn expression and Type I Interferon signaling control Echovirus 11 pathogenesis in mice.
    PLoS Pathog. 2021;17:e1009252.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.